In summary, we have provided a comprehensive genetic characterization of carefully classified NEC of the breast and show that p53 and RB pathway co-alterations are highly prevalent in SCNEC and a subset of LCNEC, similar to their counterparts in the lung35,43,44. This evidence concerns the gene TP53 and neuroendocrine carcinoma.